Japan's Otsuka Pharma has agreed to take control of US biotech Jnana Therapeutics in a deal that will give it rights to a clinical-stage candidate for the rare metabolic disorder phenylketonuria ...

Given the immense interest sparked by Nirmala Sitharaman’s post, The Times of India has made this piece free to read. Yajnadevam’s research challenges the Aryan invasion theory—was Sanskrit ...

Women had the freedom to pursue different life paths. The presence of women priests and their active participation in yajnas (sacrificial rituals) further underscores the gender inclusivity of ...